2020-11-12,Pulmatrix Reports Third Quarter 2020 Financial Results and Business Updates
2020-11-09,Pulmatrix (NASDAQ:PULM) Is In A Good Position To Deliver On Growth Plans
2020-10-21,"Pulmatrix Announces Commercial Launch of FEND, an OTC Nasal Hygiene Product Proven to Reduce Airborne Respiratory Droplets, with Partner Sensory Cloud"
2020-09-30,"Pulmatrix Announces Publication Demonstrating Reduction of Bioaerosols with FEND, an OTC Nasal Hygiene Product Designed to Cleanse Airways of Airborne Particles"
2020-09-29,Pulmatrix Strengthens Board of Directors with Appointment of Todd Bazemore
2020-09-22,Pulmatrix Reports Progress on Product Pipeline
2020-08-07,Pulmatrix Reports Q2 2020 Results and Business Updates
2020-07-08,"Pulmatrix Announces Progress by Sensory Cloud Toward Commercial Launch of FEND in Fall 2020, an OTC Nasal Hygiene Product Designed to Suppress Exhaled Airborne Particles"
2020-06-26,Pulmatrix Announces Changes to Board of Directors
2020-05-27,Pulmatrix to Host 2020 Annual Meeting of Stockholders Virtually
2020-05-14,Pulmatrix Reports Q1 2020 Results
2020-04-29,Healthcare Pro Steven Boyd Is Gobbling Up These 3 Stocks
2020-04-16,Pulmatrix Announces $8.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
2020-04-16,Pulmatrix and Sensory Cloud Announce Partnership to Develop and Commercialize a Potential Nasal Prophylactic and Anticontagion Product for COVID-19
2020-03-26,Pulmatrix Reports 2019 Financial Results and Provides Business Update
2020-01-31,The Wining Sector & Its Top Stocks in Virus-Infected January
2020-01-30,Pulmatrix Receives Fast Track Designation for Pulmazole for the Treatment of Asthma-ABPA
2020-01-16,Pulmatrix Regains Compliance with Nasdaq Minimum Bid Price Requirement
2020-01-06,Pulmatrix Announces Research Collaboration with Nocion Therapeutics to Explore Inhaled Drug Delivery Technologies
2020-01-03,Pulmatrix Surges on License Agreement With Johnson & Johnson
2020-01-02,Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Initiative at Johnson & Johnson
2019-11-04,Pulmatrix appoints Life Sciences Executive Rick Batycky to the Board of Directors
2019-11-01,Pulmatrix Reports Q3 2019 Results
2019-09-18,Pulmatrix and Cipla Announce First Patient Dosed in Phase 2 Trial Evaluating Pulmazole for Treatment of Allergic Bronchopulmonary Aspergillosis in Patients with Asthma
2019-08-19,Pulmatrix Receives US Patent Covering iSPERSE Formulations for Pulmazole Program
2019-08-05,Pulmatrix Reports Q2 2019 Results
2019-06-07,"Zacks.com featured highlights include: HP, Party City, AbbVie, OncoSec Medical and Pulmatrix"
2019-06-06,Bet on 5 Top Stocks With Rising P/E
2019-05-16,Pulmatrix Announces Leadership Change
2019-05-15,Pulmatrix Reports Q1 2019 Results
2019-04-15,Pulmatrix and Cipla Technologies LLC enter into Definitive Agreement for the Development and Commercialization of Pulmazole
2019-04-08,"Pulmatrix, Inc. Announces Closing of $16.6 Million Upsized Public Offering"
2019-04-03,"Pulmatrix, Inc. Announces Pricing of $14.4 Million Upsized Public Offering"
2019-04-01,Pulmatrix News: PULM Stock Skyrockets on Asthma Drug Deal
2019-04-01,"Pulmatrix's stock rockets after deal with Cipla Technologies to develop, commercialize asthma treatment"
2019-04-01,Pulmatrix Enters Into Binding Term Sheet with Cipla Technologies LLC for the Development and Commercialization of Pulmazole
2019-03-14,Pulmatrix to Participate in Upcoming Investor Conferences
2019-03-12,Pulmatrix Regains NASDAQ Compliance
2019-03-08,These Four Tech Stocks Could Set The Pace On Friday
2019-02-19,Pulmatrix Reports 2018 Financial Results; Provides 2019 Outlook on Pulmonary Disease Pipeline
2019-02-12,Pulmatrix Receives Five Patents Supporting Claims for their Novel Inhaled Narrow Spectrum Kinase Inhibitor Programs
2019-02-08,"Pulmatrix, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market"
2019-02-07,Pulmatrix Receives IND Approval for Pulmazole Phase 2 Clinical Study
2019-02-06,4 Biotech Stocks Making Moves on Wednesday (2/6/19)
2019-02-06,"Pulmatrix, Inc. Announces Termination of Planned Offering Pursuant to Registration Statement on Form S-1"
2019-02-05,"Pulmatrix, Inc. Announces 1-for-10 Reverse Stock Split"
2019-02-05,"Pulmatrix, Inc. Announces Closing of Public Offering of Common Stock"
2019-01-31,"Pulmatrix, Inc. Announces Closing of Public Offering of Common Stock"
2019-01-30,"Pulmatrix, Inc. Announces Pricing of Public Offering of Common Stock"
2019-01-30,"Pulmatrix, Inc. Announces Proposed Public Offering of Common Stock"
2019-01-28,"Pulmatrix, Inc. Announces Pricing of Public Offering of Common Stock"
2019-01-28,"Pulmatrix, Inc. Announces Proposed Public Offering of Common Stock"
2018-11-29,Pulmatrix Announces $3.0 Million Registered Direct Offering
2018-11-21,Pulmatrix Announces Positive Final Results from the Phase 1/1b Clinical Trial of Pulmazole - an Inhaled Dry-Powder iSPERSE Formulation of Itraconazole
2018-11-15,"Pulmatrix to Present Results from the Pulmazole (PUR1900) Phase 1/1b Study at the 2018 Annual Scientific Meeting of the American College of Allergy, Asthma, and Immunology"
2018-11-14,Pulmatrix Reports Q3 2018 Results
2018-09-18,Who Owns Most Of Pulmatrix Inc (NASDAQ:PULM)?
2018-09-17,Pulmatrix to present pre-clinical data on PUR1800 (RV1162) at the European Respiratory Society International Congress
2018-08-28,"Pulmatrix to Present at the 20th Annual Rodman & Renshaw Global Investment Conference on September 5, 2018"
2018-08-03,Pulmatrix Reports Q2 2018 Results
2018-07-23,Pulmatrix Announces the Formation of the Pulmazole Clinical Advisory Board to Support Future Development
2018-07-20,Free Technical Research on Riot Blockchain and Three More Biotech Equities
2018-07-17,Pulmatrix Announces Positive Top-Line Preliminary Results from Part 3 of the 3-Part Phase 1/1b Clinical Trial of Pulmazole - an Inhaled Dry-Powder iSPERSE Formulation of Itraconazole
2018-06-25,Pulmatrix Announces Positive Top-Line Results from Parts 1 and 2 of the 3-Part Phase 1/1b Clinical Trial of Pulmazole - an Inhaled Dry-Powder iSPERSE Formulation of Itraconazole
2018-06-13,Pulmatrix Announces Publication of Results from a Phase 1 Pharmacodynamic Study of PUR0200 in COPD Patients
2018-06-07,Pulmatrix Announces Approval of Proposals Submitted to Company's Stockholders
2018-06-04,Wired News - Madrigal Pharma Reported Encouraging Top-line Data at 36 Weeks from Phase-2 Clinical Trial of MGL-3196 in Patients with NASH
2018-06-04,Initiating Free Research Reports on Pulmatrix and Three Other Biotech Equities
2018-05-25,Interested In Pulmatrix Inc (NASDAQ:PULM)? Heres How It Performed Recently
2018-05-17,Pulmatrix selected to present company profile at the 2018 Respiratory Innovation Summit in San Diego
2018-05-11,Pulmatrix Reports Q1 2018 Results
2018-03-29,Pulmatrix Announces Pricing Of $15.2 Million Underwritten Public Offering
2018-03-13,Pulmatrix Reports 2017 Financial Results; Provides 2018 Outlook on Pulmonary Disease Pipeline
2018-03-09,Is Pulmatrix Inc (NASDAQ:PULM) A Financially Sound Company?
2018-02-12,Pulmatrix Announces First Subject Dosed in Phase 1 Clinical Trial of Pulmazole - an Inhaled Dry-Powder iSPERSE Formulation of Itraconazole
2018-01-29,Todays Research Reports on Trending Tickers: Atossa Genetics and Pulmatrix
2018-01-28,Is Pulmatrix Inc (NASDAQ:PULM) Undervalued?
2018-01-25,PULM: MHRA Authorizes CTA; Patient Screening Commences!
2018-01-24,"Pulmatrix Will Present Pulmazole Preclinical Data at the 8th Advances Against Aspergillosis Conference to be Held February 1 - 3, 2018"
2018-01-22,Pulmatrix Announces Acceptance of a Clinical Trial Application in Europe for Pulmazole - an Inhaled Dry-Powder iSPERSE Formulation of Itraconazole
2017-12-19,"How Pulmatrix Incs (NASDAQ:PULM) EPS Dropped 13.7%, Did Its Industry Show Weakness Too?"
2017-12-04,Pulmatrix Inc (PULM): Time For A Financial Health Check
2017-11-29,"Pulmatrix, Inc. :PULM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017"
2017-11-14,PULM: Business And Financial Update For Third Quarter 2017
2017-11-09,Pulmatrix Provides Q3 2017 Highlights and Q3 2017 Updated Financials
2017-10-31,Pulmatrix Presents at the North American Cystic Fibrosis Conference
2017-10-30,Pulmatrix Appoints Dr. James Roach as Chief Medical Officer
2017-10-24,Pulmatrix: Company to Watch in Lung Disease Market
2017-10-11,Is It Time To Buy Pulmatrix Inc (PULM)?
2017-10-03,"Pulmatrix Antifungal Drug Candidate Receives a Second ""Qualified Infectious Disease Product"" (QIDP) Designation from the FDA"
2017-09-27,Today's Research Reports on Trending Tickers: Opko Health and Pulmatrix
2017-09-21,"Pulmatrix to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017"
2017-09-20,Pulmatrix Receives Key Patents on its Inhaled Drug Delivery Technology and its COPD Drug
2017-09-19,Is It The Right Time To Buy Pulmatrix Inc (PULM)?
2017-09-19,CEO Robert Clarke Discusses Positive Developments from Partnerships Obtained within the Past Few Months
2017-09-19,PULM: Influx Of Grant And Partnership Deal- Signs Of Growing Confidence In Pulmatrix
2017-09-08,"Pulmatrix to Present at the Rodman & Renshaw Global Investment Conference on September 11, 2017"
2017-09-06,Pulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plc
2017-09-06,Today's Research Reports on Trending Tickers: Pulmatrix Inc. and Portola Pharmaceuticals Inc.
2017-09-06,Vectura Announces Major New Tiotropium Bromide PI Development Programme Accelerated Through Licensing of Pulmatrix Technology
